Posted on 6/27/19
Thermo Fisher Scientific Launches Next-Generation Open Air Orbital Shakers Offering Unmatched Reliability
Thermo Fisher Scientific has developed a new line of next-generation open air orbital shakers to offer unmatched reliability and superior user programmability in a compact benchtop . . .
Posted on 6/27/19
Children’s Community Health Plan Renews Relationship with Cotiviti
ATLANTA--(BUSINESS WIRE)--Children’s Community Health Plan (CCHP) has renewed its relationship with Cotiviti, a leader in data-driven healthcare solutions, to use Cotiviti’s top-performing Medical Intelligence solution. A . . .
Posted on 6/27/19
NeuroMetrix Provides Strategic Update
WALTHAM, Mass., June 27, 2019 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO), a health technology company addressing chronic health conditions including chronic pain, sleep disorders and diabetes, . . .
Posted on 6/27/19
Morphic Prices Upsized Initial Public Offering
WALTHAM, Mass.--(BUSINESS WIRE)--Morphic Holding, Inc., a biopharmaceutical company discovering and developing oral small-molecule integrin therapeutics, today announced the pricing of its upsized initial public offering of . . .
Posted on 6/26/19
PathMaker Neurosystems is Named as Recipient of France's Top Prize for Innovation
PathMaker Neurosystems Inc., a clinical-stage bioelectronic medicine company developing breakthrough non-invasive systems for the treatment of patients with spasticity and paralysis, is very pleased to announce . . .
Posted on 6/26/19
Berkshire Owns 5.8% Of Torchmark, Here Are 12 Reasons Which Might Explain Why
SummaryTorchmark is rather "unknown" but has a long history of very profitable underwriting and outperformance of the markets.Berkshire owns 5.8%, and insiders, 3.6%.Very wise capital allocation . . .
Posted on 6/26/19
Ziopharm: Awakening The Sleeping Beauty CAR-T
SummaryRiding the waves of CAR-T innovation, Ziopharm Oncology is substantially rewarding shareholders while delivering hopes to patients afflicted by deadly tumors.The company is harnessing the power . . .
Posted on 6/26/19
Ethos Veterinary Health Announces Continued Growth With The Addition of Two Hospital Groups
Ethos Veterinary Health (Ethos), a leading independent veterinary health company, today announced the addition of two hospital groups: WVRC, with three locations in Wisconsin, and Pet . . .
Posted on 6/25/19
Intensity Therapeutics Announces Clinical Collaboration with Merck
WESTPORT, Conn.--(BUSINESS WIRE)--Intensity Therapeutics, Inc., a clinical-stage biotechnology company pioneering a novel, immune-based approach to treat solid tumor cancers through direct injection of its proprietary therapeutic . . .
Posted on 6/25/19
NextGate and Life Image Partner
NextGate, the global leader in healthcare enterprise identification, and Life Image, the world's largest global network for sharing clinical and imaging data that is powered by . . .
Posted on 6/25/19
Flex Pharma Announces Broker Authority to Vote on Certain Proposals
OSTON--(BUSINESS WIRE)--Flex Pharma, Inc. (Nasdaq: FLKS) today announced that on or about June 27, 2019 it will mail a supplement to its proxy materials to provide . . .
Posted on 6/25/19
ArQule Prices $90M Public Offering
BURLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq:ARQL) today announced the pricing of an underwritten public offering of 9,250,000 shares of its common stock at a price to the . . .
Posted on 6/25/19
Amylyx Pharmaceuticals Strengthens Leadership Team
Amylyx Pharmaceuticals, Inc., today announced three additions to its executive leadership team, appointing industry veterans Patrick Yeramian, M.D., MBA, as chief medical officer
Posted on 6/25/19
Gamida Cell Launches Proposed Public Offering of Ordinary Shares
BOSTON--(BUSINESS WIRE)--Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced the launch of a proposed follow-on public offering of approximately $30.0 . . .
Posted on 6/24/19
Eloxx Pharmaceuticals Closes Public Offering of Common Stock
WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) today announced the closing of its underwritten public offering of 3,833,334 shares of . . .
Posted on 6/24/19
Bristol-Myers Squibb Provides Update on Pending Merger with Celgene
Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: CELG).
Posted on 6/24/19
Melinta Therapeutics: sNDA Acceptance Triggers 200% Gain
SummaryMelinta Therapeutics stock rockets as a result of BAXDELA's sNDA being accepted by the FDA for a priority review.The company was given a PDUFA date of . . .
Posted on 6/24/19
The Society for Public Health Education Celebrates the REACH 20th Anniversary on Capitol Hill
On June 11, 2019, the Society for Public Health Education sponsored a congressional briefing and panel discussion in celebration of the 20th Anniversary of the CDC's . . .
Posted on 6/24/19
Stoke Therapeutics Closes IPO
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company that is pioneering a new way to treat the underlying cause of genetic diseases by precisely . . .
Posted on 6/24/19
Karuna Therapeutics Readies Plan For $70 Million IPO
Karuna Therapeutics has filed to raise $70 million in a U.S. IPO.The firm is advancing a pipeline of treatment candidates for schizophrenia and other central nervous . . .
Posted on 6/21/19
bluebird bio: Returning To A Previous Winner
Summarybluebird bio's gene therapy, Zynteglo, gets the thumbs up on a conditional approval to treat patients with ß-thalassemia in the EU. However, it appears the company . . .
Posted on 6/21/19
Bristol-Myers Squibb And Celgene - On The Path To A Valuable Combination
SummaryBristol-Myers Squibb announced its plan to acquire Celgene more than 6 months ago. The deal has since been approved by shareholders from both companies.Celgene has maintained . . .
Posted on 6/21/19
Is Pfizer Overpaying for Array Biopharma?
When Pfizer (NYSE:PFE) opened up its checkbook this week to buy Array Biopharma (NASDAQ:ARRY), it was bidding for a small cancer portfolio that has big potential. But . . .
Posted on 6/20/19
Eloxx Pharmaceuticals Prices $30M Public Offering of Common Stock
WALTHAM, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (Nasdaq: ELOX) today announced the pricing of an underwritten public offering of 3,333,334 shares of . . .
Posted on 6/20/19
Flexion Therapeutics Named one of Boston Business Journal’s Best Places to Work for the Third Consecutive Year
BURLINGTON, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named one of Boston Business Journal’s “Best Places . . .

